ALXN  valuation analysis

Basics
Name: Alexion Pharmaceuticals, Inc
Description: Alexion Pharmaceuticals, Inc. develops and commercializes various therapeutic products. (more)
Industry: Biotechnology
Last 10Q10Qs are quarterly reports which contain a company's financial figures. We use these to calculate the FFER.: Feb 04, 2021
Market cap: $32.75B (197th)
Sales(TTM): $6.07B (352nd)
Earnings(TTM): $603.40M (298th)

Value
FFER: 1.67 (why)
Actual price: $148.19
FFEThis is Alexion Pharmaceuticals, Inc's the estimated price. FFEs are the denominator of the FFER ratio.: $92.74
Quantile: ALXN is expensive given its fundamentals.
Prices as of EOD 2021-03-03
Price & Estimates
Sales & Earnings history (TTM)
Notable
No notables found through heuristics.
Earnings / MarketCap
Alexion Pharmaceuticals, Inc
"Biotechnology" industry
Sales / MarketCap
Alexion Pharmaceuticals, Inc
"Biotechnology" industry
Book / MarketCap
Alexion Pharmaceuticals, Inc
"Biotechnology" industry
Equity / Assets
Alexion Pharmaceuticals, Inc
"Biotechnology" industry